Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Combining functional and structural genomics to sample the essential Burkholderia structome.

Baugh L, Gallagher LA, Patrapuvich R, Clifton MC, Gardberg AS, Edwards TE, Armour B, Begley DW, Dieterich SH, Dranow DM, Abendroth J, Fairman JW, Fox D 3rd, Staker BL, Phan I, Gillespie A, Choi R, Nakazawa-Hewitt S, Nguyen MT, Napuli A, Barrett L, Buchko GW, Stacy R, Myler PJ, Stewart LJ, Manoil C, Van Voorhis WC.

PLoS One. 2013;8(1):e53851. doi: 10.1371/journal.pone.0053851. Epub 2013 Jan 31.

2.

Burkholderia thailandensis as a model system for the study of the virulence-associated type III secretion system of Burkholderia pseudomallei.

Haraga A, West TE, Brittnacher MJ, Skerrett SJ, Miller SI.

Infect Immun. 2008 Nov;76(11):5402-11. doi: 10.1128/IAI.00626-08. Epub 2008 Sep 8.

3.

Antibiotic resistance in Burkholderia species.

Rhodes KA, Schweizer HP.

Drug Resist Updat. 2016 Sep;28:82-90. doi: 10.1016/j.drup.2016.07.003. Epub 2016 Jul 30. Review.

4.

Genome-wide saturation mutagenesis of Burkholderia pseudomallei K96243 predicts essential genes and novel targets for antimicrobial development.

Moule MG, Hemsley CM, Seet Q, Guerra-Assunção JA, Lim J, Sarkar-Tyson M, Clark TG, Tan PB, Titball RW, Cuccui J, Wren BW.

MBio. 2014 Feb 11;5(1):e00926-13. doi: 10.1128/mBio.00926-13.

5.

Genomic acquisition of a capsular polysaccharide virulence cluster by non-pathogenic Burkholderia isolates.

Sim BM, Chantratita N, Ooi WF, Nandi T, Tewhey R, Wuthiekanun V, Thaipadungpanit J, Tumapa S, Ariyaratne P, Sung WK, Sem XH, Chua HH, Ramnarayanan K, Lin CH, Liu Y, Feil EJ, Glass MB, Tan G, Peacock SJ, Tan P.

Genome Biol. 2010;11(8):R89. doi: 10.1186/gb-2010-11-8-r89. Epub 2010 Aug 27.

6.

Comparative genomics and an insect model rapidly identify novel virulence genes of Burkholderia mallei.

Schell MA, Lipscomb L, DeShazer D.

J Bacteriol. 2008 Apr;190(7):2306-13. doi: 10.1128/JB.01735-07. Epub 2008 Jan 25.

7.

Interrogation of the Burkholderia pseudomallei genome to address differential virulence among isolates.

Challacombe JF, Stubben CJ, Klimko CP, Welkos SL, Kern SJ, Bozue JA, Worsham PL, Cote CK, Wolfe DN.

PLoS One. 2014 Dec 23;9(12):e115951. doi: 10.1371/journal.pone.0115951. eCollection 2014. Erratum in: PLoS One. 2015;10(3):e0122178.

8.

Multilocus sequence typing and evolutionary relationships among the causative agents of melioidosis and glanders, Burkholderia pseudomallei and Burkholderia mallei.

Godoy D, Randle G, Simpson AJ, Aanensen DM, Pitt TL, Kinoshita R, Spratt BG.

J Clin Microbiol. 2003 May;41(5):2068-79. Erratum in: J Clin Microbiol. 2003 Oct;41(10):4913.

9.

In silico analysis of Burkholderia pseudomallei genome sequence for potential drug targets.

Chong CE, Lim BS, Nathan S, Mohamed R.

In Silico Biol. 2006;6(4):341-6.

PMID:
16922696
10.

Genomic characterization of Burkholderia pseudomallei isolates selected for medical countermeasures testing: comparative genomics associated with differential virulence.

Sahl JW, Allender CJ, Colman RE, Califf KJ, Schupp JM, Currie BJ, Van Zandt KE, Gelhaus HC, Keim P, Tuanyok A.

PLoS One. 2015 Mar 24;10(3):e0121052. doi: 10.1371/journal.pone.0121052. eCollection 2015.

11.

Burkholderia Hep_Hag autotransporter (BuHA) proteins elicit a strong antibody response during experimental glanders but not human melioidosis.

Tiyawisutsri R, Holden MT, Tumapa S, Rengpipat S, Clarke SR, Foster SJ, Nierman WC, Day NP, Peacock SJ.

BMC Microbiol. 2007 Mar 15;7:19.

12.

Genomic patterns of pathogen evolution revealed by comparison of Burkholderia pseudomallei, the causative agent of melioidosis, to avirulent Burkholderia thailandensis.

Yu Y, Kim HS, Chua HH, Lin CH, Sim SH, Lin D, Derr A, Engels R, DeShazer D, Birren B, Nierman WC, Tan P.

BMC Microbiol. 2006 May 26;6:46.

13.

Functional reconstitution, gene isolation and topology modelling of porins from Burkholderia pseudomallei and Burkholderia thailandensis.

Siritapetawee J, Prinz H, Samosornsuk W, Ashley RH, Suginta W.

Biochem J. 2004 Feb 1;377(Pt 3):579-87.

14.
15.
16.
18.

Global map of growth-regulated gene expression in Burkholderia pseudomallei, the causative agent of melioidosis.

Rodrigues F, Sarkar-Tyson M, Harding SV, Sim SH, Chua HH, Lin CH, Han X, Karuturi RK, Sung K, Yu K, Chen W, Atkins TP, Titball RW, Tan P.

J Bacteriol. 2006 Dec;188(23):8178-88. Epub 2006 Sep 22.

19.

Sequence-defined transposon mutant library of Burkholderia thailandensis.

Gallagher LA, Ramage E, Patrapuvich R, Weiss E, Brittnacher M, Manoil C.

MBio. 2013 Nov 5;4(6):e00604-13. doi: 10.1128/mBio.00604-13.

20.

Comparison of efficacy of ciprofloxacin and doxycycline against experimental melioidosis and glanders.

Russell P, Eley SM, Ellis J, Green M, Bell DL, Kenny DJ, Titball RW.

J Antimicrob Chemother. 2000 Jun;45(6):813-8.

PMID:
10837435

Supplemental Content

Support Center